User profiles for Girish N. Nadkarni
 | Girish NadkarniIcahn School of Medicine at Mount Sinai Verified email at mountsinai.org Cited by 34483 |
[HTML][HTML] Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
…, S Mukhopadhyay, JB Nachega, GN Nadkarni… - The lancet, 2020 - thelancet.com
Background Health system planning requires careful assessment of chronic kidney disease
(CKD) epidemiology, but data for morbidity and mortality of this disease are scarce or non-…
(CKD) epidemiology, but data for morbidity and mortality of this disease are scarce or non-…
[HTML][HTML] AKI in hospitalized patients with COVID-19
Background Early reports indicate that AKI is common among patients with coronavirus
disease 2019 (COVID-19) and associated with worse outcomes. However, AKI among …
disease 2019 (COVID-19) and associated with worse outcomes. However, AKI among …
[PDF][PDF] The polygenic and monogenic basis of blood traits and diseases
…, KL Mohlke, N Mononen, Y Murakami, GN Nadkarni… - Cell, 2020 - cell.com
Blood cells play essential roles in human health, underpinning physiological processes
such as immunity, oxygen transport, and clotting, which when perturbed cause a significant …
such as immunity, oxygen transport, and clotting, which when perturbed cause a significant …
Acute kidney injury in patients on SGLT2 inhibitors: a propensity-matched analysis
GN Nadkarni, R Ferrandino, A Chang… - Diabetes …, 2017 - Am Diabetes Assoc
OBJECTIVE Sodium-glucose cotransporter-2 (SGLT2) inhibitors are new medications that
improve cardiovascular and renal outcomes in patients with type 2 diabetes (T2D). However, …
improve cardiovascular and renal outcomes in patients with type 2 diabetes (T2D). However, …
Anticoagulation, bleeding, mortality, and pathology in hospitalized patients with COVID-19
GN Nadkarni, A Lala, E Bagiella, HL Chang… - Journal of the American …, 2020 - jacc.org
Background Thromboembolic disease is common in coronavirus disease-2019 (COVID-19).
There is limited evidence on the association of in-hospital anticoagulation (AC) with …
There is limited evidence on the association of in-hospital anticoagulation (AC) with …
Association of treatment dose anticoagulation with in-hospital survival among hospitalized patients with COVID-19
… Nadkarni has received financial compensation as a consultant and Advisory Board member
for and owns equity in RenalytixAI; is a scientific co-founder of RenalytixAI and Pensieve …
for and owns equity in RenalytixAI; is a scientific co-founder of RenalytixAI and Pensieve …
Factors associated with death in critically ill patients with coronavirus disease 2019 in the US
…, JG Wang, G Mosoyan, GN Nadkarni… - JAMA internal …, 2020 - jamanetwork.com
Importance The US is currently an epicenter of the coronavirus disease 2019 (COVID-19)
pandemic, yet few national data are available on patient characteristics, treatment, and …
pandemic, yet few national data are available on patient characteristics, treatment, and …
Development of a definition of postacute sequelae of SARS-CoV-2 infection
…, B Levy, GA McComsey, L McCorkell, GN Nadkarni… - Jama, 2023 - jamanetwork.com
Importance SARS-CoV-2 infection is associated with persistent, relapsing, or new symptoms
or other health effects occurring after acute infection, termedpostacute sequelae of SARS-…
or other health effects occurring after acute infection, termedpostacute sequelae of SARS-…
Association between early treatment with tocilizumab and mortality among critically ill patients with COVID-19
…, JG Wang, G Mosoyan, GN Nadkarni… - JAMA internal …, 2021 - jamanetwork.com
Importance Therapies that improve survival in critically ill patients with coronavirus disease
2019 (COVID-19) are needed. Tocilizumab, a monoclonal antibody against the interleukin 6 …
2019 (COVID-19) are needed. Tocilizumab, a monoclonal antibody against the interleukin 6 …
Multinational assessment of accuracy of equations for predicting risk of kidney failure: a meta-analysis
Importance Identifying patients at risk of chronic kidney disease (CKD) progression may
facilitate more optimal nephrology care. Kidney failure risk equations, including such factors as …
facilitate more optimal nephrology care. Kidney failure risk equations, including such factors as …
